In Search For Profits

Saturday, October 25, 2003


"Bullet" list of the TASR conference call:

  • Success rate 94% in estimated 33k incidents of Taser use.

  • Qtr to prev year qtr +216% sales, +254% profit

  • Net income from -69 to 1,076 qtr to prev year qtr

  • Qtr to prev qtr +46% sales, +41% profit

  • Great user acceptance of new Taser X26 (with better margins).


  • Taser mine long term project (5 yrs) partnership with GD for the military.

  • Long range Taser partnership with Batelle.

  • Broad patents approved an in process.

  • New VP from AH.

  • Growing US market penetration of 20% of 18,000 agencies (including top 5 PD's), 5% of 1,1 Mi officers are using Tasers.

  • Congress approved an initial $1 Mi for US Army to spend on Tasers.

  • Swiss police adopted Tasers, UK 12-month test going fenomenally well, Australia field trial showing fantastic results, this shows the trend.

  • Very large quotations coming, about 6 of them is each for more than half of the quantity ordered this entire year, the quantity for one of the quotations is more than the quantity for the entire year. One foreign military will probably buy much more next year after tests done.

  • TASR may have crossed tipping point in market momentum.

  • Pending litigations will not affect.

  • New building ready in 2004. Expected move in February.

  • 2003 net income +1,072% of 2002's.

  • Stock up 12.7 times $3.30 low in Oct/02.

  • Drop in price from May to October/2002 was not due to fundamental reasons, but because of the momentum play on the UAL order and the Cockpit Gun Bill. Airlines is a significantly smaller business and not core for TASR.


  • PE = 30 annualized basic EPS, PE = 43 on diluted EPS

  • Company growing at 100%

  • Investor relations conference in NY November/03, Chinese Investor Conference, Business Week ad

  • Marketing in Q4: IACP roundtable, TASER Europe conference, each PD will receive a customized cost & benefit report.

  • Taser platform: handhelds, long range, area denial (Taser land mine), cartridges.

  • Lithium proprietary batteries on model X26 will generate extra revenue.
The above is just the first half of the conference call and does not includes investor questions.

Click here to listen (needs Windows Media Player) or click here to watch it.

TASR $54.47 on 10/24/2003


Also check out my first posts about TASR: [1] [2]


Home | Archive
Past articles
































































































































































blog*spot
get rid of this ad | advertise here